Matthew Nelson

Matthew Nelson supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing critical procurement activities that enable public health surveillance, laboratory diagnostics, and biomedical research. He oversees the acquisition of technical services and specialized manufacturing capabilities essential to CDC’s mission of detecting and responding to infectious disease threats. His portfolio primarily includes complex contracts for computer systems design, data infrastructure, and pharmaceutical manufacturing, ensuring that federal health operations are supported by cutting-edge, scalable, and secure solutions. He works closely with technical teams to translate scientific requirements into compliant, performance-based solicitations aligned with federal acquisition regulations. Nelson maintains consistent working relationships with key contractors including General Dynamics Information Technology, Inc., MRIGLOBAL, Cepheid, GlaxoSmithKline, LLC, and the New York City Health & Hospitals Corp. These partnerships reflect a focus on high-capacity service providers with proven expertise in laboratory automation, diagnostic testing platforms, and large-scale public health data systems. His contracting approach emphasizes long-term vendor collaboration, technical compliance, and mission-critical delivery timelines, often involving complex requirements for regulatory adherence and supply chain resilience. His procurement activity shows no reliance on socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on accessing the broadest possible pool of qualified vendors capable of meeting CDC’s urgent, high-stakes public health needs without restriction, prioritizing technical capability and operational readiness over socioeconomic categorization. Nelson’s primary NAICS focus is on Computer Systems Design Services (541512) and Custom Computer Programming Services (541511), underscoring his specialization in digital health infrastructure, data processing, and analytics platforms. He also routinely procures pharmaceutical preparation manufacturing (541512) and basic organic chemical manufacturing (325199), indicating deep engagement with the biopharmaceutical supply chain. His expertise lies at the intersection of public health science and enterprise technology, ensuring that CDC’s operational capabilities are supported by robust, compliant, and scientifically validated procurement outcomes.